China’s medical big data company GENMOE WISDOM raised ￥60 million in a series B round funding led by Huagai Capital and followed by Phoenix Tree Capital Partner, Legend Capital. i Fu Rong Investment, and SK Microorganism Fund. The investment will be used to accelerate the launch of clinical application.
GENMOE WISDOM is committed to the structuralization of pathology information of NGPD, the quantification of pathology image, and smarter analysis of bio-information.
South Africa Today